Pfizer Enterprise Value:
213.40B for May 17, 2013Pfizer Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 213.40B |
| May 16, 2013 | 215.49B |
| May 15, 2013 | 217.72B |
| May 14, 2013 | 216.57B |
| May 13, 2013 | 216.35B |
| May 10, 2013 | 211.68B |
| May 9, 2013 | 210.82B |
| May 8, 2013 | 211.75B |
| May 7, 2013 | 213.91B |
| May 6, 2013 | 211.68B |
| May 3, 2013 | 213.40B |
| May 2, 2013 | 215.63B |
| May 1, 2013 | 212.97B |
| April 30, 2013 | 214.20B |
| April 29, 2013 | 223.97B |
| April 26, 2013 | 221.53B |
| April 25, 2013 | 222.75B |
| April 24, 2013 | 225.19B |
| April 23, 2013 | 228.65B |
| April 22, 2013 | 227.57B |
| April 19, 2013 | 228.50B |
| April 18, 2013 | 225.12B |
| April 17, 2013 | 227.14B |
| April 16, 2013 | 227.64B |
| April 15, 2013 | 224.12B |
| April 12, 2013 | 225.70B |
| April 11, 2013 | 225.48B |
| April 10, 2013 | 220.31B |
| April 9, 2013 | 214.48B |
| April 8, 2013 | 214.84B |
| April 5, 2013 | 214.41B |
| April 4, 2013 | 214.84B |
| April 3, 2013 | 213.91B |
| April 2, 2013 | 215.35B |
| April 1, 2013 | 212.54B |
| March 28, 2013 | 212.69B |
| March 27, 2013 | 211.10B |
| March 26, 2013 | 210.82B |
| March 25, 2013 | 207.65B |
| March 22, 2013 | 209.23B |
| March 21, 2013 | 207.29B |
| March 20, 2013 | 208.59B |
| March 19, 2013 | 206.43B |
| March 18, 2013 | 206.79B |
| March 15, 2013 | 206.65B |
| March 14, 2013 | 207.29B |
| March 13, 2013 | 206.65B |
| March 12, 2013 | 206.07B |
| March 11, 2013 | 208.30B |
| March 8, 2013 | 207.87B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
PFE Enterprise Value Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | 241.66B |
| Merck | 145.87B |
| Bristol-Myers Squibb | 76.52B |
PFE Enterprise Value Rankings
| Overall |
99th percentile 26 of 7590 |
| Sector |
99th percentile 2 of 651 in Healthcare |
| Industry |
96th percentile 2 of 52 in Drug Manufacturers - Major |
PFE Enterprise Value Range, Past 5 Years
| Minimum | 72.46B | Mar 2 2009 |
| Maximum | 228.65B | Apr 23 2013 |
| Average | 154.46B |
